Berlin – January 2026 – FGS Global, the world’s leading stakeholder strategy firm, is strengthening the firm’s capabilities in healthcare, policy, and corporate affairs with Mike Schuster, who has joined the Berlin office as Managing Director.
Mike brings more than 15 years of experience at the intersection of healthcare policy, biotechnology, and strategic communications. Before joining FGS Global, he spent over four years at BioNTech, where he drove engagement on key health and life sciences issues. Throughout his career, Mike has developed and executed integrated public affairs strategies across the life sciences sector, combining expertise in health policy, regulatory frameworks, and corporate affairs. Prior to BioNTech, he held various roles in public affairs and health policy, advising global healthcare companies and institutions on innovative healthcare and legislative cooperation.
At FGS Global, Mike will focus on further expanding the firm’s healthcare and public policy offering in Germany and across Europe, helping clients navigate complex regulatory environments, advance innovation, and foster trust among policymakers and stakeholders. Working closely with the firm’s international teams, he will provide strategic counsel at the intersection of policy, reputation and transformation.
Christoph Bertram, Partner, Member of the European Exco, commented: "We're building the leading healthcare policy practice in Europe, and Mike is central to that ambition. His impressive experience in politics and business coupled with his deep regulatory knowledge will be invaluable to clients navigating Europe's evolving healthcare landscape."
Mike said: “I am delighted to join FGS Global at such an exciting time for the healthcare sector in Europe. With the sector undergoing rapid transformation, I look forward to partnering with our clients and colleagues to shape forward-looking strategies that advance innovation and deliver sustainable impact for patients and society.”